Purdue Pharma Dissolved: OxyContin Settlement Takes Effect | STAT News

Purdue Pharma, the manufacturer of the prescription painkiller OxyContin, is set to be dissolved and replaced by a new company focused on the public good. This transition is expected to be completed by the end of the week of May 1, 2026, as a massive legal settlement resolving thousands of lawsuits takes effect.

The dissolution follows a critical legal milestone reached on April 28, 2026, when U.S. District Judge Madeline Cox Arleo delivered a criminal sentence to the company. This sentencing was designed to resolve a probe conducted by the Department of Justice and served as the final necessary step to clear the way for the broader settlement.

Judicial Proceedings and Victim Impact

Before reaching her decision, Judge Arleo spent hours listening to impact statements from individuals directly affected by the opioid crisis. These statements came from people who had struggled with addiction themselves or those who had lost loved ones to the epidemic.

Some of the individuals providing testimony requested that the judge reject the negotiated sentence. While Judge Arleo did not grant those requests, she stated that she sympathized with the people who bore the brunt of the crisis.

Public Health Context

The legal actions against Purdue Pharma are situated within a broader public health emergency. The opioid epidemic has been linked to more than 900,000 deaths in the United States since 1999.

The transition of the company into an entity focused on the public good is part of the resolution of thousands of lawsuits that sought to address the harms caused by the company’s role in the epidemic.